Toth Financial Advisory’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-20
| Closed | -$1.46K | – | 798 |
|
|
2023
Q3 | $1.46K | Hold |
20
| – | – | ﹤0.01% | 673 |
|
|
2023
Q2 | $1.66K | Hold |
20
| – | – | ﹤0.01% | 657 |
|
|
2023
Q1 | $1.53K | Hold |
20
| – | – | ﹤0.01% | 694 |
|
|
2022
Q4 | $1.66K | Hold |
20
| – | – | ﹤0.01% | 606 |
|
|
2022
Q3 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 655 |
|
|
2022
Q2 | – | Sell |
-30
| Closed | -$3K | – | 776 |
|
|
2022
Q1 | $3K | Buy |
+30
| New | +$3K | ﹤0.01% | 598 |
|
|
2021
Q2 | – | Sell |
-125
| Closed | -$17K | – | 741 |
|
|
2021
Q1 | $17K | Buy |
+125
| New | +$17K | ﹤0.01% | 403 |
|
|
2019
Q2 | – | Sell |
-800
| Closed | -$72K | – | 479 |
|
|
2019
Q1 | $72K | Buy |
800
+100
| +14% | +$9K | 0.02% | 191 |
|
|
2018
Q4 | $50K | Sell |
700
-300
| -30% | -$21.4K | 0.01% | 184 |
|
|
2018
Q3 | $96K | Hold |
1,000
| – | – | 0.02% | 180 |
|
|
2018
Q2 | $95K | Buy |
1,000
+300
| +43% | +$28.5K | 0.02% | 176 |
|
|
2018
Q1 | $61K | Hold |
700
| – | – | 0.01% | 202 |
|
|
2017
Q4 | $59K | Buy |
+700
| New | +$59K | 0.01% | 199 |
|
|
2016
Q1 | – | Sell |
-7,600
| Closed | -$534K | – | 117 |
|
|
2015
Q4 | $534K | Buy |
+7,600
| New | +$534K | 0.18% | 87 |
|